PARP inhibition enhances tumor cell–intrinsic immunity in ERCC1-deficient non–small cell lung cancer
Roman M. Chabanon(Université Paris-Sud), Sophie Postel‐Vinay(Université Paris-Sud)
Cited by 322
Related Papers
Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines
|Cell Reports|2016|109
DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade
|Journal of Clinical Investigation|2018|29
Replication Stress Is an Actionable Genetic Vulnerability in Desmoplastic Small Round Cell Tumors
|Cancer Research|2024|5